Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KLIO - Non-interventional Multicenter Prospective and Retrospective Study to Describe Treatment Patterns and Disease Control in Patients With Classical Hodgkin's Lymphoma (cHL) and Systemic Anaplastic Large Cell Lymphoma (sALCL) in Routine Clinical Practice in the Russian Federation

NCT03942263 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03942263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03942263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KLIO - Non-interventional Multicenter Prospective and Retrospective Study to Describe Treatment Patterns and Disease Control in Patients With Classical Hodgkin's Lymphoma (cHL) and Systemic Anaplastic Large Cell Lymphoma (sALCL) in Routine Clinical Practice in the Russian Federation
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
May 31, 2019
Completion date
December 8, 2022
Enrollment
2,000 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease, lymphoma, large-cell, anaplastic